Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > TCBP TC BioPharm > Detailed Quotes

TCBP TC BioPharm

Watchlist
5.120
-0.100-1.92%
Close  01/31 16:00 ET
5.1200.0000.00%
Pre Mkt Price 02/01 04:05 ET
High
5.500
Open
5.120
Turnover
2.74M
Low
4.800
Pre Close
5.220
Volume
531.13K
Market Cap
4.86M
P/E(TTM)
Loss
52wk High
175.000
Shares
949.96K
P/E(Static)
Loss
52wk Low
2.810
Float Cap
3.35M
Bid/Ask %
0.00%
Historical High
175.000
Shs Float
654.71K
Volume Ratio
0.18
Historical Low
2.810
Dividend TTM
--
Div Yield TTM
--
P/B
3.97
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
81.13%
Amplitude
13.41%
Avg Price
5.160
Lot Size
1
Float Cap
3.35M
Bid/Ask %
0.00%
Historical High
175.000
Shs Float
654.71K
Volume Ratio
0.18
Historical Low
2.810
Dividend TTM
--
P/B
3.97
Dividend LFY
--
Turnover Ratio
81.13%
Amplitude
13.41%
Avg Price
5.160
Lot Size
1
Price Forecast

News

Comment

Company Overview More
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.
CEO: Mr. Bryan Kobel
Market: NASDAQ
Listing Date: 02/11/2022
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist